Transanal vs Laparoscopic TME and Disease-Free Survival in Patients With Rectal Cancer
This randomized, open-label, phase 3 clinical trial investigates whether transanal total mesorectal excision is noninferior to laparoscopic total mesorectal excision in 3-year disease-free survival in patients with mid-low rectal cancer.
This randomized, open-label, phase 3 clinical trial investigates whether transanal total mesorectal excision is noninferior to laparoscopic total mesorectal excision in 3-year disease-free survival in patients with mid-low rectal cancer.
